CLINICAL SYNDROMES AND BIOCHEMICAL ALTERATIONS FOLLOWING MESCALINE, LYSERGIC ACID DIETHYLAMIDE, PSILOCYBIN AND A COMBINATION OF THE THREE PSYCHOTOMIMETIC DRUGS.
D035843:Biomedical Research; D001769:Blood; D001786:Blood Glucose; D002118:Calcium; D002712:Chlorides; D003401:Creatine; D003404:Creatinine; D004644:Emotions; D005227:Fatty Acids; D005989:Glycerides; D006213:Hallucinogens; D006801:Humans; D008238:Lysergic Acid Diethylamide; D008635:Mescaline; D010758:Phosphorus; D011562:Psilocybin; D011581:Psychological Tests; D011600:Psychopharmacology; D013577:Syndrome; D014556:Urine
D001786:Blood Glucose; D002712:Chlorides; D005227:Fatty Acids; D005989:Glycerides; D006213:Hallucinogens; D010758:Phosphorus; D011562:Psilocybin; D008238:Lysergic Acid Diethylamide; D003404:Creatinine; D003401:Creatine; D008635:Mescaline; D002118:Calcium
BLOOD; BLOOD SUGAR; CALCIUM; CHLORIDES; CLINICAL RESEARCH; CREATINE AND CREATININE; EMOTIONS; FATTY ACIDS; GLYCERIDES; HALLUCINOGENS; LYSERGIC ACID DIETHYLAMIDE; MESCALINE; PHOSPHORUS; PSILOCYBINE; PSYCHOLOGICAL TESTS; PSYCHOPHARMACOLOGY; URINE